Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 221268

In scope icon N/A
QID 221268 (Type "221268" in App Search)
A 61-year-old G2P2 woman presents with a 1 month history of incontinence. She has been leaking urine at night, especially in the later hours of the night before she wakes up. She has not noticed any leakage with coughing, laughing, or urge to urinate. She has tried drinking less water and doing pelvic floor exercises without benefit. Her medical is significant for diabetes as well as 2 spontaneous vaginal deliveries with an epidural for pain control. Her temperature is 98.6°F (37.0°C), blood pressure is 115/70 mmHg, pulse is 70/min, and respirations are 12/min. A bladder scan is obtained with the results shown in Figure A and a post-void residual volume of 525 cc. Which of the following is the most appropriate next step in management?
  • A

Administer bethanchol

0%

0/0

Administer oxybutynin

0%

0/0

Administer topical estrogen

0%

0/0

Begin intermittent urinary catheterization

0%

0/0

Place an indwelling Foley catheter

0%

0/0

  • A

Select Answer to see Preferred Response

This patient with urinary leakage at night and an increased post-void residual, most likely has overflow incontinence secondary to diabetes. The most appropriate management of overflow incontinence due to diabetes is bethanchol.

Overflow incontinence is a condition of chronic urinary retention, featuring a chronically distended bladder due to detrusor underactivity or outlet obstruction that leads to urinary leakage with overfilling. The diagnosis of overflow incontinence can be made with postvoid residual measurements and urodynamic testing. Overflow incontinence is associated with neurogenic bladder such as in multiple sclerosis or diabetes and bladder outlet obstruction (such as in benign prostatic hyperplasia). The most appropriate medical treatment for this condition is bethanchol, which is a parasympathetic choline analogue. Placement of a urethral catheter may be necessary in acute settings to allow the patient to void.

MacLachlan and Rovner review the evidence regarding the diagnosis and treatment of incontinence in women. They discuss how incontinence can be classified into overflow, stress, urge, and mixed incontinence. They recommend bethanchol for overflow incontinence.

Figure/Illustration A is a bladder ultrasound demonstrating increased urine in the bladder (red circle). This finding is consistent with overflow incontinence.

Incorrect Answers:
Answer 2: Oxybutynin is an antimuscarinic agent used for the treatment of urinary urgency and overactive bladder. It would worsen overflow incontinence.

Answer 3: Topical estrogen can be used in patients who have stress incontinence in the setting of menopause. This would present with incontinence during coughing, sneezing, laughing, and physical exertion.

Answers 4 & 5: Intermittent catheterization is the preferred management for overflow urinary retention compared to indwelling Foley catheters, since indwelling catheters have a higher complication rate than intermittent catheterization, including a higher risk of subsequent urinary tract infection. In initial cases, medical management with bethanchol should be attempted before catheterization.

Bullet Summary:
Overflow incontinence is initially managed with medications such as bethanchol.

ILLUSTRATIONS:
REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)